(19)
(11) EP 4 543 829 A1

(12)

(43) Date of publication:
30.04.2025 Bulletin 2025/18

(21) Application number: 23741867.8

(22) Date of filing: 21.06.2023
(51) International Patent Classification (IPC): 
C07B 59/00(2006.01)
A61P 25/00(2006.01)
C07D 471/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/04; C07B 59/002; C07B 2200/13; A61P 25/00; C07B 2200/05
(86) International application number:
PCT/US2023/025826
(87) International publication number:
WO 2023/249989 (28.12.2023 Gazette 2023/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.06.2022 US 202263354448 P

(71) Applicant: GENZYME CORPORATION
Cambridge, Massachusetts 02141 (US)

(72) Inventors:
  • DEMONTIGNY, Pierre
    Cambridge, Massachusetts 02141 (US)
  • SIEGEL, Craig S.
    Cambridge, Massachusetts 02141 (US)
  • YANG, Donglai
    Cambridge, Massachusetts 02141 (US)

(74) Representative: Cabinet Nony 
11 rue Saint-Georges
75009 Paris
75009 Paris (FR)

   


(54) SOLID FORMS OF DEUTERATED COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS